The future of Pharma R&D

R&D has traditionally been and will continue to be (probably even more) crucial for the growth and future success of research-based pharma companies. The pharmaceutical industry has now entered a period of significant uncertainty and transition characterized by higher R&D costs, depleted pipelines and financial restriction to perform innovative research. The global credit crunch exacerbates all this with more and more layoffs and research budget cuts, but major crisis can sometimes produce major opportunities. 


    Related Conference of The future of Pharma R&D

    May 12-13, 2025

    19th International Conference on Obesity Medicine

    Toronto, Canada
    June 24-25, 2025

    3rd Global Summit on HIV-AIDS and STDs

    Chicago, USA
    July 21-22, 2025

    24th International Conference on Genomics and Molecular Biology

    Aix-en-Provence, France
    August 07-08, 2025

    12th World Summit on Epilepsy and Bipolar Disorders

    Paris, France
    August 25-26, 2025

    8th International Conference on Community Nursing and Public Health

    Singapore City, Singapore
    September 19-20, 2025

    9th International Conference on Internal Medicine

    Aix-en-Provence, France
    September 22-23, 2025

    39th International Conference on Cancer Science & Therapy

    Amsterdam, Netherlands
    September 22-23, 2025

    17th Annual Congress on Drug Formulation & Analytical Techniques

    Amsterdam, Netherlands
    October 16-17, 2025

    19th International Conference on Pathology and Laboratory Medicine

    Aix-en-Provence, France
    November 03-04, 2025

    5th World Medicine Congress

    Rome, Italy
    November 21-22, 2025

    5th International Conference on Medical Research and Development

    Amsterdam, Netherlands

    The future of Pharma R&D Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in